
Hepatag 25000IU Injection
Marketer
Ikon Remedies Pvt Ltd
Salt Composition
Heparin (25000IU)
Overview Hepatag 25000IU Injection
Heparin 25000IU Injection acts as a blood thinner, preventing the development and growth of potentially dangerous clots within the circulatory system, including the legs, lungs, and heart. Administered under strict medical guidance, the dosage frequency is determined and adjusted by your physician based on individual response. Consistent use is crucial for optimal effectiveness, regardless of perceived well-being, as its preventative action safeguards against future complications. Regular blood tests will be conducted to monitor treatment efficacy and assess potassium and platelet levels. Increased bleeding risk is associated with this medication; report any signs of unusual bleeding (e.g., petechiae, hematuria, melena) immediately. Exercise caution with activities involving sharp objects or potential injury. Prior to commencing treatment, disclose all pre-existing health conditions and medications to your doctor. Pregnant patients should seek medical counsel regarding the medication's safety.
Uses of Hepatag 25000IU Injection
Thrombosis prophylaxis
Major Benefits of Hepatag 25000IU Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Hepatag 25000IU Injection:
- Bleeding
- Erythema (skin redness)
How to use Hepatag 25000IU Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Hepatag 25000IU Injection works:
Hepatag 25000IU Injection acts as a blood thinner, inhibiting the development of dangerous blood clots. While it doesn't break down pre-existing clots, it effectively prevents their expansion and the subsequent obstruction of blood vessels.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption while using Hepatag 25000IU Injection is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The use of Hepatag 25000IU Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Patient consultation with their doctor is advised.
Breast feedingSAFE IF PRESCRIBED
Hepatag 25000IU Injection presents minimal risk during lactation. Research in humans indicates negligible transfer into breast milk, posing no apparent danger to the infant. The insignificant quantities of Hepatag 25000IU Injection detected in breast milk result in minuscule infant exposure, insufficient to produce adverse reactions.
DrivingSAFE
Driving ability is typically unaffected by Hepatag 25000IU Injection.
KidneySAFE IF PRESCRIBED
Hepatag 25000 IU Injection can be administered to patients with kidney disease without altering the dosage. Nevertheless, disclosure of any pre-existing renal impairment to your physician is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Hepatag 25000IU Injection's application in individuals with hepatic impairment. Physician consultation is recommended.
What if you forget to take Hepatag 25000IU Injection :
Should you forget a scheduled Hepatag 25000IU Injection, seek medical advice immediately.
Facts to Know About Hepatag 25000IU Injection
| Label | Value |
|---|---|
| Chemical Category | Glycosaminoglycan Sulfate |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Behavior Class | Unfractionated Heparin |
